Glycopyrrolate Injection Recall Due to Hair Contamination
Fresenius Kabi is recalling Glycopyrrolate Injection due to the presence of particulate matter, specifically hair found in the product.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving particulate matter (hair) in an injectable drug product. No illnesses or injuries have been reported, and the contamination is classified as a moderate risk rather than a high-risk pathogen or allergen mislabeling.
Plain-English summary
Fresenius Kabi USA, LLC is recalling Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), packaged in multiple dose vials. The product was distributed nationwide within the USA in tray and vial configurations under NDC numbers 633323-578-05 and 633323-578-07.
The recall is being issued due to the presence of particulate matter, specifically hair found in the product. The affected lots are 6134349 and 6134620 with an expiration date of November 2026.
Healthcare facilities and pharmacies that received the affected product should immediately check their inventory, quarantine any remaining units, and contact Fresenius Kabi to arrange for return or replacement. The total quantity involved in the recall is 59,425 vials.
No adverse events or injuries have been reported in connection with this recall. Consumers or healthcare providers with questions should contact Fresenius Kabi USA, LLC directly.
The recalled product
- Product
- GLYCOPYRROLATE (GLYCOPYRROLATE)
- Brand
- GLYCOPYRROLATE
- Manufacturer
- Fresenius Kabi USA, LLC
- Category
- Drug — Injection / Injectable
- Hazard
- particulate-matter
- foreign-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 6134349
- 6134620 Exp. Date 11/2026
UPCs (3)
- 0363323578046
- 0363323578039
- 0363323578077
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · GLYCOPYRROLATE
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate oral solution recalled after failing impurity and degradation specifications
FDA (Drugs) · 2026-02-04
- ModerateGlycopyrrolate Tablets Recalled Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2023-06-28
- ModerateGlycopyrrolate Injection Vials Recalled Due to Labeling Mix-up
FDA (Drugs) · 2023-06-14
- HighGlycopyrrolate Injection Recalled Due to Manufacturing Quality Deviations
FDA (Drugs) · 2023-03-08
Same category
- SevereMajor Pharmaceuticals Recalls Levothyroxine Sodium Tablets Over Subpotency
FDA (Drugs) · 2026-07-29
- HighLevothyroxine Sodium Tablets Recalled Due to Subpotent Drug Concerns
FDA (Drugs) · 2026-07-29
- HighNaropin Injection Recall Over Particulate Matter Contamination
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29